Hormone-dependent placental manipulation of breast cancer cell migration

Human Reproduction

Volumn 27, Issue 1, 2012, Pages 73-88

  Epstein Shochet, G ^a,b   Tartakover Matalon, S ^a,b   Drucker, L ^a,b   Pomeranz, M ^a,b   Fishman, A ^a,b   Rashid, G ^a   Oron Karni, V ^b   Pasmanik Chor, M ^b   Lishner, M ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

breast cancer cells; motility; placenta; pregnancy

Indexed keywords

ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE 10; PROGESTERONE; SYNAPTOPHYSIN;

ARTICLE; BREAST CANCER; CELL MIGRATION; CELL MOTILITY; CELL STRAIN MCF 7; EXPLANT; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PLACENTA; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION;

EID: 83755185560     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der365     Document Type: Article

References (65)

1. Al-Adnani M, Kiho L, Scheimberg I. Maternal pancreatic carcinoma metastatic to the placenta: a case report and literature review. Pediatr Dev Pathol 2007;10:61-65. (Pubitemid 350177704)
2. Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, Noyes RD, Bowen GM, Leachman SA. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 2003;21:2179-2186. (Pubitemid 46606367)
3. Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy: a review of the literature Parts I-II. Obstet Gynecol Survey 1996; 51:125-142.
4. Bourdeau V, Deschenes J, Laperriere D, Aid M, White JH, Mader S. Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Res 2008; 36:76-93.
5. Boyd JD, Hamilton WJ. The Human Placenta. Cambridge: Heffer, 1970.
6. Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D. Regulation of aromatase expression in breast cancer tissue. Ann N Y Acad Sci 2009; 1155:121-131.
7. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006; 38:1289-1297. (Pubitemid 44646291)
8. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009;37:305-311.
9. Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F, Pasqualini J.R. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 2000;72:23-27. (Pubitemid 30145713)
10. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-3253. (Pubitemid 37430077)
11. Chu YW, Wang R, Schmid I, Sakamoto KM . Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry 1999;36:333-339. (Pubitemid 29344469)
12. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 1990;11:266-301. (Pubitemid 20182871)
13. Dressing GE, Lange CA. Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation. Steroids 2009;74:573-576.
14. Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, Cavailles V. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 2007; 67:5513-5521. (Pubitemid 46997293)
15. Faivre E, Skildum A, Pierson-Mullany L, Lange CA. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 2005;70:418-426. (Pubitemid 40616040)
16. Folkerd EJ, Dowsett M. Influence of sex hormones on cancer progression. J Clin Oncol 2010;28:4038-4044.
17. Fu XD, Giretti MS, Baldacci C, Garibaldi S, Flamini M, Sanchez AM, Gadducci A, Genazzani AR, Simoncini T. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One 2008a;3:e2790.
18. Fu XD, Giretti MS, Goglia L, Flamini MI, Sanchez AM, Baldacci C, Garibaldi S, Sitruk-Ware R, Genazzani AR, Simoncini T. Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC Cancer 2008b;8:166.
19. Fujita D, Tanabe A, Sekijima T, Soen H, Narahara K, Yamashita Y, Terai Y, Kamegai H, Ohmichi M. Role of extracellular signal-regulated kinase and Akt cascades in regulating hypoxia-induced angiogenic factors produced by a trophoblast-derived cell line. J Endocrinol 2010; 206:131-140.
20. Genbacev O, Miller RK. Three-dimensional culture of placental villuos tissue explants: an in vitro model for peri-implantation. Methods Toxicol 1993;3B:246-260.
21. Genbacev O, Schubach SA, Miller RK. Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 1992;13:439-461.
22. Genbacev O, Jensen KD, Powlin SS, Miller RK. In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. Placenta 1993;14:463-475. (Pubitemid 23256336)
23. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997;18:502-519. (Pubitemid 27349554)
24. Heikaus S, Winterhager E, Traub O, Grummer R. Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens. J Mol Endocrinol 2002;29:239-249. (Pubitemid 35276612)
25. Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet 1995; 346:883.
26. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264.
27. Jackisch C, Louwen F, Schwenkhagen A, Karbowski B, Schmid KW, Schneider HP, Holzgreve W. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 2003;268:69-77. (Pubitemid 36753453)
28. Jacobs IA, Chang CK, Salti GI. Coexistence of pregnancy and cancer. Am Surg 2004;70:1025-1029.
29. Kumar P, Kamat A, Mendelson CR. Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta. Mol Endocrinol 2009;23:784-793.
30. Lange CA. Challenges to defining a role for progesterone in breast cancer. Steroids 2008;73:914-921.
31. Lechner D, Bajna E, Adlercreutz H, Cross HS. Genistein and 17beta-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res 2006;26:2597-2603. (Pubitemid 44155540)
32. Li Y, Wang JP, Santen RJ, Kim TH, Park H, Fan P, Yue W. Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology 2010;151:5146-5156.
33. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976;36:4595-4601.
34. Lostumbo A, Mehta D, Setty S, Nunez R. Flow cytometry: a new approach for the molecular profiling of breast cancer. Exp Mol Pathol 2006; 80:46-53. (Pubitemid 41828226)
35. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009;14:87-98.
36. McGowan EM, Saad S, Bendall LJ, Bradstock KF, Clarke CL. Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts. Breast Cancer Res Treat 2004; 83:211-220. (Pubitemid 38264869)
37. Mullick A, Katzenellenbogen BS. Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. Evidence for a non-hormone binding receptor precursor. J Biol Chem 1986;261:13236-13246.
38. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F, Carazo JM, Pascual-Montano A. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 2009;37:317-322.
39. Pages C, Robert C, Thomas L, Maubec E, Sassolas B, Granel-Brocard F, Chevreau C, De Raucourt S, Leccia MT, Fichet D et al. Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol 2010;162:274-281.
40. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004;64:423-428. (Pubitemid 38114127)
41. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 2002; 7:279-287. (Pubitemid 34919954)
42. Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 2008;34:302-312.
43. Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol 2005;18:26-35. (Pubitemid 40128091)
44. Sasano H, Miki Y, Nagasaki S, Suzuki T. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Pathol Int 2009;59:777-789.
45. Schindler AE. Endocrinology of pregnancy: consequences for the diagnosis and treatment of pregnancy disorders. J Steroid Biochem Mol Biol 2005; 97:386-388. (Pubitemid 41691875)
46. Shaw LM. Tumor cell invasion assays. Methods Mol Biol 2005;294:97-105.
47. Shousha S. Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med 2000;124:1053-1060. (Pubitemid 30602049)
48. Shuhaila A, Rohaizak M, Phang KS, Mahdy ZA. Maternal melanoma with placental metastasis. Singapore Med J 2008;49:e71-e72. (Pubitemid 351549322)
49. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003;189:1128-1135. (Pubitemid 37373909)
50. Smyth CM, Benn DE, Reeve TS. Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies. Breast Cancer Res Treat 1988;11:45-50.
51. Snyder EM, Small CL, Li Y, Griswold MD. Regulation of gene expression by estrogen and testosterone in the proximal mouse reproductive tract. Biol Reprod 2009;81:707-716.
52. Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC,Winder AD, Reiter R, Wellstein A, Martin MB et al. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 2003;22:7998-8011. (Pubitemid 37175864)
53. Strauss JF III, Martinez F, Kiriakidou M. Placental steroid hormone synthesis: unique features and unanswered questions. Biol Reprod 1996;54:303-311. (Pubitemid 26031398)
54. Sukocheva OA, Yang Y, Gierthy JF. Estrogen and progesterone interactive effects in postconfluent MCF-7 cell culture. Steroids 2009;74:410-418.
55. Sumida T, Itahana Y, Hamakawa H, Desprez PY. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins. Cancer Res 2004;64:7886-7892. (Pubitemid 39446922)
56. Tartakover-Matalon S, Mizrahi A, Epstein G, Shneifi A, Drucker L, Pomeranz M, Fishman A, Radnay J, Lishner M. Breast cancer characteristics are modified by first trimester human placenta: in vitro co-culture study. Hum Reprod 2010;25:2441-2454.
57. Thelmo MC, Shen EP, Shertukde S. Metastatic pulmonary adenocarcinoma to placenta and pleural fluid: clinicopathologic findings. Fetal Pediatr Pathol 2010;29:45-56.
58. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB, Lippman ME. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res 1988;48:6764-6768. (Pubitemid 19012202)
59. Tomita T, Sawamura F, Uetsuka R, Chiba T, Miura S, Ikeda M, Tomita I. Inhibition of cholesterylester accumulation by 17 beta-estradiol in macrophages through activation of neutral cholesterol esterase. Biochim Biophys Acta 1996;1300:210-218. (Pubitemid 26194122)
60. Turgeon JL, Waring DW. Progesterone regulation of the progesterone receptor in rat gonadotropes. Endocrinology 2000; 141:3422-3429. (Pubitemid 32269032)
61. Ulery M, Carter L, McFarlin BL, Giurgescu C. Pregnancy-associated breast cancer: significance of early detection. J Midwifery Womens Health 2009; 54:357-363.
62. Velarde MC, Zeng Z, McQuown JR, Simmen FA, Simmen RC. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells. Mol Endocrinol 2007;21:2988-3001. (Pubitemid 350223509)
63. Welshons WV, Wolf MF, Murphy CS, Jordan VC. Estrogenic activity of phenol red. Mol CellEndocrinol 1988;57:169-178.
64. Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg 2003;138:91-98; discussion 99. (Pubitemid 36055657)
65. Zheng ZY, Lin VC. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7. Cancer Lett 2008;268:202-211.